Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice

Male 0301 basic medicine 570 type 1 diabetes Immunology microbiome Gene Expression Autoimmune Disease Microbiology Autoimmune Diseases Mice 03 medical and health sciences Mice, Inbred NOD cecal material transfer Diabetes Mellitus 2.1 Biological and endogenous factors Animals histone modification Aetiology Cecum Metabolic and endocrine Pediatric microRNA Bacteria Animal Diabetes autoimmune animal models Anti-Bacterial Agents Gastrointestinal Microbiome Histone Code Intestines Disease Models, Animal MicroRNAs Good Health and Well Being Diabetes Mellitus, Type 1 5.1 Pharmaceuticals Medical Microbiology Disease Models gene expression Inbred NOD Metagenome Female Development of treatments and therapeutic interventions innate immune NOD mice Metabolic Networks and Pathways Type 1
DOI: 10.1016/j.chom.2021.06.014 Publication Date: 2021-07-21T17:27:52Z
ABSTRACT
Early-life antibiotic exposure perturbs the intestinal microbiota and accelerates type 1 diabetes (T1D) development in the NOD mouse model. Here, we found that maternal cecal microbiota transfer (CMT) to NOD mice after early-life antibiotic perturbation largely rescued the induced T1D enhancement. Restoration of the intestinal microbiome was significant and persistent, remediating the antibiotic-depleted diversity, relative abundance of particular taxa, and metabolic pathways. CMT also protected against perturbed metabolites and normalized innate and adaptive immune effectors. CMT restored major patterns of ileal microRNA and histone regulation of gene expression. Further experiments suggest a gut-microbiota-regulated T1D protection mechanism centered on Reg3γ, in an innate intestinal immune network involving CD44, TLR2, and Reg3γ. This regulation affects downstream immunological tone, which may lead to protection against tissue-specific T1D injury.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (135)
CITATIONS (47)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....